Are Biochemical Blood Tests Necessary for Diagnosing FIP

Feline Infectious Peritonitis (FIP) is one of the most challenging and enigmatic diseases affecting domestic cats. Caused by certain mutations of the feline coronavirus (FCoV), FIP is notorious for its varied clinical signs, rapid progression, and a high mortality rate. As FIP remains difficult to diagnose definitively, veterinarians often rely on a combination of clinical findings, history, laboratory tests, and sometimes advanced imaging or tissue biopsies. Among these, biochemical blood tests are frequently used. But how necessary and decisive are they in the diagnosis of FIP? Understanding this is crucial, not only for practitioners but also for cat owners navigating the uncertainty that comes with this diagnosis.

FIP: Context and Challenges

FIP typically arises when particular genetic changes occur in the otherwise widespread and usually harmless feline enteric coronavirus. While many cats carry the benign virus without ever falling ill, some develop FIP, which manifests either as "wet" (effusive) or "dry" (non-effusive) forms, distinguished by the presence or absence of fluid accumulation in body cavities.

The initial signs—lethargy, reduced appetite, fever, and weight loss—are vague and overlap with many other illnesses. Even more specific symptoms such as abdominal distension, respiratory distress, or neurological signs do not reliably distinguish FIP from other diseases. As a result, laboratory tests, including biochemical blood tests, have become an integral part of the diagnostic algorithm.

Role of Biochemical Blood Tests

Biochemical blood tests measure levels of various substances in the blood, providing a snapshot of organ function, protein concentrations, and electrolyte balance. In suspected FIP cases, several markers are routinely analyzed:

Total Protein and Albumin/Globulin Ratio: FIP often causes an increase in total protein due to elevated globulins, resulting in a decreased albumin/globulin (A/G) ratio.

Liver Enzymes (ALT, AST, ALP): Mild elevations may occur if the liver is involved.

Bilirubin: May be increased, particularly in advanced cases.

Urea and Creatinine: These may provide information about kidney function, which is sometimes compromised.

Electrolytes: Altered concentrations can reflect dehydration or abdominal fluid shifts.

Alpha-1 acid glycoprotein (AGP): Less commonly measured, this acute phase protein may be notably high in FIP.

What’s important about these observations is not necessarily the presence of a single abnormal value, but rather the pattern of changes that, when interpreted alongside the clinical picture, can raise or lower suspicion for FIP.

Are Biochemical Blood Tests Sufficient for Diagnosis?

Despite their utility, the answer is nuanced. The elevation of globulins, the drop in A/G ratio, and other findings are not exclusive to FIP; they may also occur in other infectious, inflammatory, or neoplastic diseases. Therefore, biochemical blood tests alone cannot offer a definitive diagnosis.

For instance, decreased A/G ratio—classically <0.8—and elevated total protein are frequently cited as hallmarks of FIP. However, chronic inflammatory conditions such as lymphoma, toxoplasmosis, or other infections can produce similar laboratory profiles. Some cats with FIP may not show dramatic changes, especially in the early phases, which can lead to misinterpretation.

AGP is gaining traction for its specificity, but even it is not utterly exclusive to FIP. Elevated levels may be seen in other systemic inflammatory conditions. Thus, while blood biochemistry is essential for capturing the broader health picture, it must be interpreted alongside clinical findings, history, and, often, further diagnostic tests.

Complementary Diagnostic Strategies

Given the limitations above, veterinarians rarely rely solely on biochemical blood tests. Instead, a layered approach is taken:

1. Clinical Assessment: Age (typically young cats), breed (some purebreds overrepresented), and exposure history are considered. Wet or dry forms are differentiated based on clinical signs and imaging.

2. CBC and Biochemical Profile: These track the pattern and progression of changes, such as lymphopenia, neutrophilia, hyperglobulinemia.

3. Imaging (Ultrasound or X-ray): Identifies effusions, organ enlargement, or masses.

4. Analysis of Effusions: In the wet form, abdominal or thoracic fluid is sampled to check for high protein content, low cellularity, and characteristic cytology.

5. FCoV Detection: RT-PCR or immunohistochemistry can identify viral RNA or antigens, but detecting FCoV itself is not diagnostic without corroborative clinical signs.

6. Histopathology (Biopsy): Tissue samples may reveal granulomatous lesions. Detection of coronavirus-positive macrophages is considered highly confirmatory.

Through integration of the above, the likelihood of FIP is assessed, and a working diagnosis made. Biochemical blood tests are indispensable for ruling in or out differentials, monitoring progression, and guiding supportive management, but they rarely stand alone.

Biochemical Blood Tests: Value in Monitoring

Once FIP is suspected or confirmed, ongoing blood tests have another vital role—monitoring treatment response and disease progression. Changes in protein levels, hepatic or renal values, and other markers offer insights into the cat’s evolving condition, guiding therapy adjustments.

For instance, a normalization of globulin levels, improved A/G ratio, or lowering of AGP might signal therapeutic success, though not all cases respond predictably. Cats on emerging treatments such as antiviral GS-441524 derivatives may demonstrate laboratory improvement before clinical improvement, making labs invaluable for early detection of complications.

Pitfalls and Potential for Misdiagnosis

While biochemical blood values can support the suspicion of FIP, misinterpretation remains a serious risk. Over-reliance on single lab findings without context can lead to false positives—potentially initiating unnecessary, costly, or even harmful treatments. Alternatively, missing subtle biochemical clues could delay intervention.

Certain breeds, like Bengals and other pedigrees, show variations in baseline globulin and protein levels, complicating the interpretation of ratios. Stress, concurrent infections, or dehydration also influence lab values, creating overlap with FIP findings.

A core principle in internal medicine is pattern recognition, not single data point reliance. Biochemical blood tests must serve as a piece, not the whole, of the diagnostic puzzle.

Innovations and Future Directions

Recent advances are elevating the precision of FIP diagnosis. AGP and other acute-phase proteins measured on panels may become more standardized, allowing for more accurate stratification of inflammatory diseases. Molecular techniques such as PCR on tissue biopsies, improved imaging modalities, and more sensitive immunoassays continue to refine the diagnostic toolbox.

Emerging artificial intelligence algorithms may soon help interpret complex patterns from blood biochemistry, cross-referencing with clinical databases to flag probable FIP cases. However, these innovations remain aids, not replacements, for experienced clinical judgment.

Clinical Case Example

A three-year-old domestic shorthair presents with lethargy, decreased appetite, and abdominal distension. Biochemical blood tests reveal elevated total protein (9.5 g/dL), decreased A/G ratio (0.7), and mild elevation of liver enzymes. Ultrasound demonstrates a moderate abdominal effusion of high protein content. The fluid cytology and AGP levels support a diagnosis of FIP.

Yet, without the integration of history, clinical presentation, and imaging, the same blood findings could indicate lymphoma, toxoplasmosis, or another inflammatory process. Follow-up with PCR for FCoV sequence and, if feasible, biopsy or immunohistochemistry provides additional confirmation.

Practical Takeaways

Biochemical blood tests are essential but not independently diagnostic for FIP.

Interpretation requires pattern recognition across multiple markers, never in isolation.

Serial monitoring helps guide therapy and assess response.

Integration with history, clinical signs, imaging, and advanced diagnostics is mandatory to avoid misdiagnosis.

Ongoing research may refine specificity and reliability, but clinical acumen remains central.

References

1. Pedersen, N. C. (2014). An update on feline infectious peritonitis: diagnostics and therapeutics. Veterinary Journal, 201(2), 133-141.

2. Tasker, S. (2018). Diagnosis of feline infectious peritonitis: update on evidence supporting laboratory testing and clinical diagnosis. Journal of Feline Medicine and Surgery, 20(3), 228-242.

3. Felten, S., & Hartmann, K. (2019). Diagnosis of feline infectious peritonitis: a review of the current literature. Viruses, 11(11), 1068.

4. Dempsey, S. M., & Ewing, P. J. (2011). A review of the diagnosis and treatment of feline infectious peritonitis. Journal of Veterinary Internal Medicine, 25(4), 771-779.

5. Watson, A. (2019). Laboratory findings in feline infectious peritonitis. The Veterinary Nurse, 10(1), 28-33.

6. Kipar, A., & Meli, M. L. (2014). Feline infectious peritonitis: still an enigma?. Veterinary Pathology, 51(2), 505-526.

7. Paltrinieri, S. (2018). The diagnostic approach to feline infectious peritonitis: A review. Journal of Feline Medicine and Surgery, 20(7), 650-661.

8. Addie, D. D., & Jarrett, O. (1995). Feline coronavirus infections. In Infectious Diseases of the Dog and Cat (pp. 58-66).

9. Stranieri, A., Lauzi, S., Giordano, A., et al. (2018). Serum protein electrophoresis and acute phase protein in cats. Veterinaria Italiana, 54(1), 27-31.

10. Barker, E. N., Tasker, S., Gruffydd-Jones, T. J., et al. (2015). Evaluation of alpha-1 acid glycoprotein as a diagnostic marker for feline infectious peritonitis. Journal of Feline Medicine and Surgery, 17(10), 901-909.